As BAP1 is commonly inactivated in MPM and its germline mutation is linked to MPM and other cancers, this study found that BAP1-deficient cells experienced changes in arginine metabolism, leading to increased ASS1 expression and altered sensitivity to arginine deprivation by ADI-PEG 20. The gene discussed is BAP1; the disease is cancer.